Madrigal Pharmaceuticals, Inc. (MDGL)
529.88
+5.60
(+1.07%)
USD |
NASDAQ |
May 27, 14:59
Madrigal Pharmaceuticals Free Cash Flow : -275.41M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Insmed, Inc. | -951.64M |
| ACADIA Pharmaceuticals, Inc. | 113.59M |
| PTC Therapeutics, Inc. | -516.78M |
| Protagonist Therapeutics, Inc. | -117.90M |
| Altimmune, Inc. | -71.67M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -167.44M |
| Cash from Investing (Quarterly) | 192.19M |
| Cash from Financing (Quarterly) | 2.329M |
| Free Cash Flow Per Share (Quarterly) | -5.900 |
| Free Cash Flow to Equity (Quarterly) | -170.96M |
| Free Cash Flow to Firm (Quarterly) | -163.46M |
| Free Cash Flow Yield | -2.15% |